Retinoic Acid, all trans CAS: 302-79-4
MF: C20H28O2
MW: 300.4
An activator of RAR and RXR and used in stem cells.

Retinoic Acid, all trans (CAS 302-79-4)

  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 131ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
5
1
4
0
3
0
2
0
1
0
Sinônimo Vitamin A acid
Aplicação An activator of RAR and RXR and used in stem cells
Numero VAT: 302-79-4
Privada: ≥98%
Peso Molecular: 300.4
Separar por Funcao: C20H28O2
Supplemental Information: This is classified as a Dangerous Good for transport and may be subject to additional shipping charges.
* Refere-se a Certificado de Análise para data especifica de lotes (incluindo-se o conteúdo de agua).
Faça a sua avaliação desse produto e receba 15 CruzCredits

Retinoic Acid, all trans is the oxidized carboxylic acid form of retinol, known in the dietary context as Vitamin A. Retinal (sc-210778) is the aldehyde form of retinol required by the retina of the eye for light absorption and visual processing. Retinoic acid and the other retinoids are involved in a broad range of biological regulations, mediating differentiation, proliferation, and apoptosis. Binding of Retinoic Acid to the nuclear receptors RAR (retinoic acid receptor) and the RXR (retinoid X receptor) initiate signals for transcription and development. The intimate relationship between retinoids and cell cycle regulation has been implicated in suppression of oncogenic proliferation. Also available in a photoactivatable, caged form (sc-202089).


Referencias

1. Leid, M., et al., 1992. Multiplicity generates diversity in the retinoic acid signalling pathways. Trends in biochemical sciences. 17(10): 427-33. PMID: 1333659
2. Allenby, G., et al., 1994. Binding of 9-cis-retinoic acid and all-trans-retinoic acid to retinoic acid receptors alpha, beta, and gamma. Retinoic acid receptor gamma binds all-trans-retinoic acid preferentially over 9-cis-retinoic acid. The Journal of biological chemistry. 269(24): 16689-95. PMID: 8206989
3. Napoli, J L., et al., 1996. Biochemical pathways of retinoid transport, metabolism, and signal transduction. Clinical immunology and immunopathology. 80(3 Pt 2): S52-62. PMID: 8811064
4. Bushue, Nathan., et al., 2010. Retinoid pathway and cancer therapeutics. Advanced drug delivery reviews. 62(13): 1285-98. PMID: 20654663

Estado físico :
Solid
envie :
Soluble in DMSO (25 mg/mL), ethanol (10 mg/mL), acetate, DMF (20 mg/mL), dimethyl sulfoxide (25 mg/mL), chloroform (40 mg/mL), methanol, acetone (30 mg/mL), and dichloromethane. Insoluble in water, and ether. It is recommended that solutions be made fresh for each use.
Manutencao :
Store at -20° C
Ponto de fusão :
180-181° C (lit.)
Ponto de fervura :
~462.80° C at 760 mmHg (Predicted)
Densidade :
1.01 g/cm3
Indice de produtos :
n20D 1.56
IC50 :
Retinoic acid receptor gamma: IC50 = 0.62 nM (human); Retinoic acid receptor alpha: IC50 = 5 nM (mus musculus); Herpesvirus 4: IC50 = 15.4 nM (human)
Data ki :
Retinoic acid receptor gamma: Ki= 0.7 nM (human); Retinoic acid receptor beta: Ki= 0.5 nM (human); Retinoic acid receptor alpha: Ki= 0.1 nM (human)
Valores de pK :
pKa: 4.73
Para uso em exclusivo em pesquisa. Não se destina a uso em diagnostico e tratamento.
WGK Alemanha :
2
RTECS :
VH6475000
PubChem CID :
444795
Indice de produtos :
14: 8165
Numero de FAX :
MFCD00001551
Numero de FAX :
206-129-0
Registro Beilstein :
2057223
SMILES :
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C

Baixar SDS (MSDS)

Certificado de Análise

É necessário o Adobe Acrobat Reader para visualizar corretamente,
imprimir e comentar os documentos PDF

Retinoic Acid, all trans  Citacoes dos Produtos

Visualizar com outras pessoas usaram Retinoic Acid, all trans. Clique em PubMed para ver .

Citações 1 para 10 de 12 total

PMID: # 29072505  Pastorková, B. et al. 2017. Drug Chem Toxicol. 41: 1-7.

PMID: # 26345577  Briceño, A. et al. 2016. Neurotox Res. 29: 381-93.

PMID: # 26898150  Venne, P. et al. 2016. J Chromatogr A. 1438: 57-64.

PMID: # 26208032  Illés, P. et al. 2015. J. Agric. Food Chem. 63: 7074-83.

PMID: # 20547768  Apostolatos, H. et al. 2010. J Biol Chem. -.

PMID: # 20096012  Britschgi, A. et al. 2010. Br. J. Haematol. 149: 55-64.

PMID: # 18511453  Wang, C. et al. 2008. J. Biochem. 144: 313-321.

PMID: # 18280257  Kiningham, KK. et al. 2008. Free Radic. Biol. Med. 44: 1610-1616.

PMID: # 17596541  Soriano, AO. et al. 2007. Blood. 110: 2302-2308.

PMID: # 17283134  Ohnuma-Ishikawa, K. et al. 2007. Cancer Res. 67: 1019-1029.

Citações 1 para 10 de 12 total
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 123ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 10ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;

A Santa Cruz Biotecnologia, Inc. é a líder mundial no desenvolvimento de produtos para o mercado de pesquisa biomédica. Ligue para nós ligação gratuita 1-800-457-3801..
Direito de Reprodução© 2007-2020 Santa Cruz Biotechnology, Inc. Todos os direitos reservados. "Santa Cruz Biotechnology", Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", "EZ Touch" são marcas registradas da Santa Cruz Biotechnology, Inc. Todas as marcas registradas são propriedade dos seus respectivos donos.